Probability of normal tissue complications for hematologic and gastrointestinal toxicity in postoperative whole pelvic radiotherapy for gynecologic malignancies using intensity-modulated proton therapy with robust optimization
Journal of Radiation Research · 2024
DOI: 10.1093/jrr/rrae008 ↗Kurz gefasst
Fachartikel in der Zeitschrift Journal of Radiation Research, 2024. Verfasst von Takaaki Yoshimura und 12 weiteren Autor:innen. Beteiligte Einrichtung: Department of Health Sciences and Technology, Faculty of Health Sciences, Hokkaido University, Sapporo 060-0812, Japan. Hauptthemen laut MEDLINE: Genital Neoplasms, Female, Radiotherapy, Intensity-Modulated, Proton Therapy, Radiotherapy Planning, Computer-Assisted. Die Arbeit wurde bisher 4-mal zitiert (Crossref) und nennt 49 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: JSPS KAKENHI, Regional R&D Proposal-Based Program from Northern Advancement Center for Science & Technology of Hokkaido Japan.
Abstract (Originalsprache)
This retrospective treatment-planning study was conducted to determine whether intensity-modulated proton therapy with robust optimization (ro-IMPT) reduces the risk of acute hematologic toxicity (H-T) and acute and late gastrointestinal toxicity (GI-T) in postoperative whole pelvic radiotherapy for gynecologic malignancies when compared with three-dimensional conformal radiation therapy (3D-CRT), intensity-modulated X-ray (IMXT) and single-field optimization proton beam (SFO-PBT) therapies. All plans were created for 13 gynecologic-malignancy patients. The prescribed dose was 45 GyE in 25 fractions for 95% planning target volume in 3D-CRT, IMXT and SFO-PBT plans and for 99% clinical target volume (CTV) in ro-IMPT plans. The normal tissue complication probability (NTCP) of each toxicity was used as an in silico surrogate marker. Median estimated NTCP values for acute H-T and acute and late GI-T were 0.20, 0.94 and 0.58 × 10−1 in 3D-CRT; 0.19, 0.65 and 0.24 × 10−1 in IMXT; 0.04, 0.74 and 0.19 × 10−1 in SFO-PBT; and 0.06, 0.66 and 0.15 × 10−1 in ro-IMPT, respectively. Compared with 3D-CRT and IMXT plans, the ro-IMPT plan demonstrated significant reduction in acute H-T and late GI-T. The risk of acute GI-T in ro-IMPT plan is equivalent with IMXT plan. The ro-IMPT plan demonstrated potential clinical benefits for reducing the risk of acute H-T and late GI-T in the treatment of gynecologic malignances by reducing the dose to the bone marrow and bowel bag while maintaining adequate dose coverage to the CTV. Our results indicated that ro-IMPT may reduce acute H-T and late GI-T risk with potentially improving outcomes for postoperative gynecologic-malignancy patients with concurrent chemotherapy.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Department of Health Sciences and Technology, Faculty of Health Sciences, Hokkaido University, Sapporo 060-0812, Japan.
- Department of Medical Physics, Hokkaido University Hospital, Sapporo 060-8648, Japan.
- Global Center for Biomedical Science and Engineering, Faculty of Medicine, Hokkaido University, Sapporo 060-8648, Japan.
- Department of Radiation Technology, Hokkaido University Hospital, Sapporo 060-8648, Japan.
- Department of Radiation Oncology, Hokkaido University Hospital, Sapporo 060-8648, Japan.
- Faculty of Engineering, Hokkaido University, Sapporo 060-8638, Japan.
Förderung
- JSPS KAKENHI
- Regional R&D Proposal-Based Program from Northern Advancement Center for Science & Technology of Hokkaido Japan
Zitieren
APA
Yoshimura, T., Yamada, R., Kinoshita, R., Matsuura, T., Kanehira, T., Tamura, H., Nishioka, K., Yasuda, K., Taguchi, H., Katoh, N., Kobashi, K., Hashimoto, T., & Aoyama, H. (2024). Probability of normal tissue complications for hematologic and gastrointestinal toxicity in postoperative whole pelvic radiotherapy for gynecologic malignancies using intensity-modulated proton therapy with robust optimization. Journal of Radiation Research. https://doi.org/10.1093/jrr/rrae008
Vancouver
Yoshimura T, Yamada R, Kinoshita R, Matsuura T, Kanehira T, Tamura H, et al. Probability of normal tissue complications for hematologic and gastrointestinal toxicity in postoperative whole pelvic radiotherapy for gynecologic malignancies using intensity-modulated proton therapy with robust optimization. Journal of Radiation Research. 2024. doi:10.1093/jrr/rrae008
BibTeX
@article{Yoshimura2024,
author = {Yoshimura, Takaaki and Yamada, Ryota and Kinoshita, Rumiko and Matsuura, Taeko and Kanehira, Takahiro and Tamura, Hiroshi and Nishioka, Kentaro and Yasuda, Koichi and Taguchi, Hiroshi and Katoh, Norio and Kobashi, Keiji and Hashimoto, Takayuki and Aoyama, Hidefumi},
title = {Probability of normal tissue complications for hematologic and gastrointestinal toxicity in postoperative whole pelvic radiotherapy for gynecologic malignancies using intensity-modulated proton therapy with robust optimization},
journal = {Journal of Radiation Research},
year = {2024},
doi = {10.1093/jrr/rrae008}
}
EUVIMED